title: Prognostic factors in dogs with lymphoma and associated hypercalcemia.
abstract: Lymphoma and hypercalcemia were diagnosed in 37 dogs. Twenty-six of the dogs received chemotherapy. The association between some prognostic factors including clinical stage of disease, illness status, presence of bone marrow involvement, and presence of an anterior mediastinal mass and remission duration and survival time was evaluated. Statistical analysis of the prognostic factors showed that the presence of an anterior mediastinal mass had an adverse effect on remission duration (P less than 0.03). Calcium concentration was not significantly related to any of the prognostic factors evaluated. Dogs that received chemotherapy were more likely to be self-supporting than the dogs that were not treated (P less than 0.005). However, initial illness status was not significantly related to remission duration or survival time in the 26 dogs that were treated. Six dogs (25% of dogs treated) survived longer than 14 months. Five of these dogs were female. Overall mean and median remission times were 10.4 and 6 months, respectively.
authors.affiliation: Donaldson-Atwood Cancer Clinic, Animal Medical Center, New York, NY 10021.
authors.forename: M P
authors.initials: MP
authors.lastname: Rosenberg
authors.forename: R E
authors.initials: RE
authors.lastname: Matus
authors.forename: A K
authors.initials: AK
authors.lastname: Patnaik
mesh_terms: D000818:Animals; D003404:Creatinine / Q000097:blood; D004283:Dog Diseases / Q000175:diagnosis* / Q000188:drug therapy; D004285:Dogs; D005260:Female; D006934:Hypercalcemia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D008223:Lymphoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D008297:Male; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies
chemical_list: D003404:Creatinine